Join the Invest in Holland team at the 30th anniversary edition of BIO-Europe in Stockholm, Sweden. This major conference and partnering event in the life sciences sector will provide opportunities to connect with potential partners in the global life science ecosystem to propel innovation, featuring topics like big data, AI-diagnostics, drug discovery, precision, and predictive and preventative medicine. Click here to register for the conference.

Connect and meet with the Invest in Holland team

The Invest in Holland Life Sciences and Health team is excited to connect with leading organizations from across the globe at BIO-Europe this November. Our expert team will be on hand each day to chat about expanding your business to the Netherlands. Reach out to us via partneringONE or contact the Invest in Holland team directly: Gerard Lenstra and Jan Zuidema.

You can also meet us at the Exhibitor Booth of Health~Holland (booth #86).

Advancing regenerative medicine in the Netherlands

Make impact in the field of regenerative medicine in the Netherlands, Europe’s connected life sciences metropolis. The Netherlands’ world-class life sciences & health ecosystem provides companies with ample opportunity to find success. Not only ranks the Netherlands among the top 5 in the world in the field of regenerative medicine, but the country is one of the few places in Europe where (stem) cell therapy is also applied and developed clinically.

Owned by the Leiden University Medical Center (LUMC), NECSTGEN, the Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies, is the largest non-profit stem cell and gene therapy facility in the Netherlands, and one of the largest facilities in Europe. In the NECSTGEN facility researchers and startups from Europe and beyond translate research and early-stage clinical programs into patient treatments.

Collaboration on innovative neurodegenerative therapies

With neurodegenerative disorders being among this century’s major health care challenges, the development of treatments for the degenerative processes is taking a flight in the Netherlands with foreign companies joining the Dutch ecosystem. A prime example is U.S.-based QurAlis. The company opened its European headquarters in Leiden where it is developing precision medicines for neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Committed to making a global impact, QurAlis and the Dutch ecosystem are building a healthier world together through innovative biotechnological advancements.

Other global companies like Instant NanoBiosensors, have also established a European presence in the Netherlands. The Taiwan-based diagnostic technology company has located in Utrecht from where it will continue to advance its technology aimed at ultra-sensitive blood biomarkers, particularly in Alzheimer’s disease and related neurodegenerative conditions diagnostics.

Find out how you can accelerate your business in the Netherlands and contact us at BIO Europe!